Showing results (51-60 of 130) with videos related to
Sort By:
Pageof 13
Journal of Nuclear Medicine Technology|May 17, 2008
CT artifact recognition for the nuclear technologistRobert Popilock, Kumar Sandrasagaren, Lowell Harris, et al.Journal of Clinical Pathology|June 1, 1991
Cachexia and tumour necrosis factor-alpha in cytomegalovirus infectionH Tilg, W Vogel, M Herold, et al.Current Cancer Drug Targets|May 17, 2007
The kinase inhibitor imatinib--an immunosuppressive drug?D Wolf, H Tilg, H Rumpold, et al.The Journal of Experimental Medicine|November 1, 1993
Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cellsH Tilg, E Vannier, G Vachino, et al.Zeitschrift Fur Gastroenterologie|November 23, 2006
[Endoscopy in IBD. A Consensus Report of the IBD Working of the Austrian Association of Gastroenterology and Hepatology]W Petritsch, W Tillinger, H Vogelsang, et al.Zeitschrift Fur Gastroenterologie|September 30, 2004
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD]W Reinisch, C Dejaco, P Knoflach, et al.Transplantation|April 1, 1992
Interleukin-8 serum concentrations after liver transplantationH Tilg, M Ceska, W Vogel, et al.Heliyon|May 19, 2022
The choroid-sclera interface: An ultrastructural studyC Platzl, A Kaser-Eichberger, A Benavente-Perez, et al.Gut|January 15, 2002
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gammaH Tilg, C van Montfrans, A van den Ende, et al.Blood|January 1, 1994
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55H Tilg, E Trehu, M B Atkins, et al.Pageof 13